| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells | Lin K.-W.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 35 | 33 | |
| 2009 | 2′-Ethoxy-5′-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion | Lo H.-M.; TUR-FU HUANG ; Lin C.-N.; Peng H.-C.; Wu W.-B. | Pharmacology | 1 | 1 | |
| 2011 | Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells | Tu H.-Y.; Huang A.-M.; Teng C.-H.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 16 | 14 | |
| 2014 | Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer | Lin K.-W.; Huang A.-M.; Lin C.-C.; Chang C.-C.; Hsu W.-C.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Pharmacology | 16 | 12 | |
| 2011 | Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS | Cheng J.-H.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Medicinal Chemistry | 40 | 40 | |
| 2015 | Capsular polysaccharide is involved in NLRP3 inflammasome activation by Klebsiella pneumoniae serotype K1 | Hua K.-F.; Yang F.-L.; Chiu H.-W.; Chou J.-C.; Dong W.-C.; Lin C.-N.; Lin C.-Y.; Wang, Jin-Town ; Li L.-H.; Chiu H.-W.; Chiu Y.-C.; Wu S.-H. | Infection and Immunity | 15 | 22 | |
| 2014 | Chalcone derivatives inhibit human platelet aggregation and inhibit growth in human bladder cancer cells | Wu C.-M.; Lin K.-W.; Teng C.-H.; Huang A.-M.; Chen Y.-C.; Yen M.-H.; Wu W.-B.; YEONG-SHIAU PU ; Lin C.-N. | Biological and Pharmaceutical Bulletin | 14 | 15 | |
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; SHU-WHA LIN | Thrombosis and Haemostasis | 1 | 1 | |
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; Shen M.-C.; JAU-TSUEN KAO ; Lin S.-W. | Thrombosis and Haemostasis | 1 | 1 | |
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; MING-CHING SHEN ; Kao J.-T.; Lin S.-W. | Thrombosis and Haemostasis | 1 | ||
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; YUNG-LI YANG ; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; Lin S.-W. | Thrombosis and Haemostasis | 1 | 1 | |
| 1994 | Characterization of a factor IX variant with a glycine207 to glutamic acid mutation | SHU-WHA LIN ; Lin C.-N.; Hamaguchi N.; Smith K.J.; Shen M.-C. | Blood | 6 | 6 | |
| 1994 | Characterization of a factor IX variant with a glycine207 to glutamic acid mutation | Lin S.-W.; Lin C.-N.; Hamaguchi N.; Smith K.J.; MING-CHING SHEN | Blood | 6 | ||
| 2018 | Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan | Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.; Wang L.-S.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH; Infection Control Society of Taiwan | International Journal of Antimicrobial Agents | 14 | 13 | |
| 2018 | Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan | Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.; Wang L.-S.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH ; Infection Control Society of Taiwan | International Journal of Antimicrobial Agents | 14 | 13 | |
| 2011 | Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan | Tsai H.-Y.; Chueh L.-L.; Lin C.-N.; Su B.-L.; BI-LING SU | Journal of Feline Medicine and Surgery | 23 | 26 | |
| 2012 | Cytotoxic and antioxidant constituents from Garcinia subelliptica | Lin K.-W.; Huang A.-M.; Yang S.-C.; Weng J.-R.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | Food Chemistry | 28 | 22 | |
| 2009 | Field strain feline coronaviruses with small deletions in ORF7b associated with both enteric infection and feline infectious peritonitis | Lin C.-N.; Su B.-L.; Huang H.-P.; Lee J.-J.; Hsieh M.-W.; Chueh L.-L.; BI-LING SU | Journal of Feline Medicine and Surgery | 22 | 25 | |
| 2010 | FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis | Kao C.-Y.; Lin C.-N.; Yu I.-S.; Tao M.-H.; Wu H.-L.; Shi G.-Y.; Yang Y.-L.; JAU-TSUEN KAO ; Lin S.-W. | Thrombosis and Haemostasis | 10 | 10 | |
| 2010 | FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis | Kao C.-Y.; Lin C.-N.; Yu I.-S.; Tao M.-H.; Wu H.-L.; Shi G.-Y.; Yang Y.-L.; Kao J.-T.; SHU-WHA LIN | Thrombosis and Haemostasis | 10 | 10 |
